Findings of increased hepatic AEBP1 expression in NASH patients with fibrosis led us to ask whether the gene was differentially regulated during myofibroblastic transformation of hepatic stellate cells (HSCs), the key fibrogenic cells of the liver. The gene discussed is AEBP1; the disease is metabolic dysfunction-associated steatohepatitis.